Insulin stimulates endothelial NO (nitric oxide) synthesis via PKB (protein kinase B)/Akt-mediated phosphorylation and activation of eNOS (endothelial NO synthase) at Ser-1177. In previous studies, we have demonstrated that stimulation of eNOS phosphorylation at Ser-1177 may be required, yet is not sufficient for insulin-stimulated NO synthesis. We therefore investigated the role of phosphorylation of eNOS at alternative sites to Ser-1177 as candidate parallel mechanisms contributing to insulinstimulated NO synthesis. Stimulation of human aortic endothelial cells with insulin rapidly stimulated phosphorylation of both Ser-615 and Ser-1177 on eNOS, whereas phosphorylation of Ser-114, Thr-495 and Ser-633 was unaffected. Insulin-stimulated Ser-615 phosphorylation was abrogated by incubation with the PI3K (phosphoinositide 3-kinase) inhibitor wortmannin, infection with adenoviruses expressing a dominant-negative mutant PKB/Akt or pre-incubation with TNFα (tumour necrosis factor α), but was unaffected by high culture glucose concentrations. Mutation of Ser-615 to alanine reduced insulin-stimulated NO synthesis, whereas mutation of Ser-615 to aspartic acid increased NO production by NOS in which Ser-1177 had been mutated to an aspartic acid residue. We propose that the rapid PKB-mediated stimulation of phosphorylation of Ser-615 contributes to insulinstimulated NO synthesis.
INTRODUCTION
Type 2 diabetes is associated with a greatly increased risk of atherosclerosis, yet the molecular mechanisms that underlie this association remain poorly characterized. Endothelial dysfunction, characterized by reduced NO (nitric oxide) bioavailability, is a key early event in the development of atherosclerosis (reviewed in [1] ). NO is a key regulator of vascular homoeostasis, synthesized by eNOS (endothelial NO synthase). Insulin is a direct-acting vasodilator in intact vessels that has been proposed to contribute to the maintenance of vascular health [2] [3] [4] , and we and others have demonstrated that insulin stimulates NO synthesis in cultured human endothelial cells [5, 6] . Insulin-stimulated NO synthesis is, at least in part, the result of PI3K (phosphoinositide 3-kinase) activation and the subsequent stimulation of PKB (protein kinase B/Akt), with resultant phosphorylation and activation of eNOS at Ser-1177 [6, 7] . Furthermore, we have demonstrated previously that culture of HAECs (human aortic endothelial cells) in high glucose abrogated insulin-stimulated NO synthesis, without altering insulin-stimulated phosphorylation of eNOS at Ser-1177 or Ca 2+ -stimulated NO synthesis [6] . These findings indicate that stimulation of PKB and subsequent phosphorylation of eNOS Ser-1177 may be required, yet not sufficient, for insulin-stimulated NO synthesis under certain conditions. This, in turn, suggests that insulin-stimulated NO synthesis is mediated by more than one signalling mechanism. One candidate mechanism that might underlie insulin-stimulated NO synthesis independent of Ser-1177 phosphorylation is the regulation of eNOS by phosphorylation at sites other than Ser-1177. We have demonstrated previously that phosphorylation of eNOS at Thr-495 is unaffected by insulin [6] . Phosphorylation of eNOS at Ser-114, Ser-615 and Ser-633 have been reported to regulate eNOS activity in response to various stimuli [8] [9] [10] [11] , yet the effect of acute insulin stimulation on eNOS phosphorylaton at these alternative sites has yet to be determined. In the present study we investigated the role of phosphorylation of eNOS at alternative sites to Ser-1177 as potential mechanisms contributing to insulin-stimulated NO synthesis.
EXPERIMENTAL

Materials
Cryopreserved HAECs were purchased from Promocell, and large-vessel endothelial cell medium obtained from TCS Cellworks. Human eNOS cDNA cloned into pcDNA3.1 was a gift from Professor Keith Channon (University of Oxford, Oxford, U.K.). NADPH, phenformin and BH 4 (tetrahydrobiopterin) were obtained from Sigma. CaM (calmodulin) was obtained from Merck. Rabbit anti-phospho-eNOS (Ser-116) (07-357), anti-phospho-eNOS (Ser-617) (07-561) and anti-phospho-eNOS (Ser-635) (07-562) (corresponding to Ser-114, Ser-615 and Ser-633 in human eNOS) antibodies were obtained from Upstate Biotechnologies. All other reagents were from sources described previously [6, 12, 13] .
HAECs were grown in large-vessel endothelial cell medium and passaged when at 80% confluence, as described previously [6, 12, 13] . Cells were used for experiments between passages three and six. HeLa cells were maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % (v/v) fetal calf serum, 100 units/ml penicillin and 100 mg/l streptomycin, in a humidified atmosphere of 95 % air/5 % CO 2 (v/v) at 37
• C.
Preparation of adenoviruses and infection of HAECs
Adenoviruses expressing dominant-negative PKB (Ad.PKB-DN), constitutively active mutant PKB (Ad.PKB-CA) or control adenoviruses (Ad.control) were propagated and purified as described previously [14] . HAECs were infected with 5 pfu (plaque-forming units) of adenovirus/cell in complete medium, and the cells were cultured for 48 h prior to experimentation, with the final 24 h in serum-free medium. Under these conditions after infection with a GFP (green fluorescent protein)-expressing virus, the majority (> 95 %) of HAECs expressed GFP.
Site-directed mutagenesis of eNOS
Ser615Asp, Ser615Ala, Ser1177Asp and Ser1177Ala mutations were introduced into human eNOS using a QuikChange ® site-directed mutagenesis kit (Stratagene) using the following primers: Ser615Ala (Ala-615) forward, 5 -ATAAGATCCGCT-TCAACGCCATCTCCTGCTCAGACCC-3 and reverse, 5 -GGGTCTGAGCAGGAGATGGCGTTGAAGCGGATCTTAT-3 ; Ser615Asp (Asp-615) forward, 5 -ATAAGATCCGCTTCAAC-GACATCTCCTGCTCAGACCC-3 and reverse, 5 -GGGTCT-GAGCAGGAGATGTCGTTGAAGCGGATCTTAT-3 ; Ser1177-Ala (Ala-1177) forward, 5 -GCCGCATACGCACCCAGGCCTT-TTCCTTGCAGGAGCG-3 and reverse, 5 -CGCTCCTGCAAG-GAAAAGGCCTGGGTGCGTATGCGGC-3 ; and Ser1177Asp (Asp-1177) forward, 5 -GCCGCATACGCACCCAGGACTTTT-CCTTGCAGGAGCG-3 and reverse, 5 -CGCTCCTGCAAGG-AAAAGTCCTGGGTGCGTATGCGGC-3 . Mutant generation was confirmed by sequencing analysis (University of Dundee Sequencing Service, University of Dundee, Dundee, U.K.).
Transfection of HeLa cells
Mutant DNA (2 μg/well) was mixed with Lipofectamine TM 2000 (4 μl/well; Invitrogen) in Opti-MEM reduced serum medium (200 μl; Invitrogen) and was added to HeLa cells plated on 12-well plates in serum-free culture medium without antibiotics. Cells were incubated for 24 h in the presence or absence of insulin for the final 5 min, washed with ice-cold PBS and icecold lysis buffer [50 mM Tris/HCl (pH 7.4) at 4
• C, 50 mM NaF, 1 % (v/v) Triton X-100, 250 mM mannitol, 5 mM Na 4 P 2 O 7 , 1 mM Na 2 VO 3 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM benzamidine, 0.1 mM PMSF and 5 mg/l soya bean trypsin inhibitor (80 μl)] was added to each well. Cells were scraped into a fresh microcentrifuge tube and centrifuged (11 000 g, 3 min, 4
• C). The supernatant was then collected and stored at −20
• C prior to analysis.
Preparation of cell lysates, SDS/PAGE and Western blot analysis
Cell lysates were prepared, proteins resolved by SDS/PAGE and subjected to Western blot analysis with the antibodies indicated, as described previously [6, 12, 13] .
Evaluation of NO synthesis in cell lysates
Cell lysates (100 μg) were added to 100 μl of 25% (v/v) 2 -5 -ADP-Sepharose in HBS [Hepes-buffered saline; (135 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 11.6 mM Hepes/NaOH (pH 7.3)], and the volume was made up to 300 μl with HBS. After incubation at 4
• C for 3 h on a rotating mixer, beads were washed twice with 1 ml of HBS, twice with 1 ml of HBS containing 2 mM EGTA and twice with 1 ml of HBS. Pellets were resuspended in 250 μl of assay buffer (HBS containing 30 μM BH 4 , 100 μM L-arginine, 1 mM CaCl 2 and 3 mM NADPH) and divided into 50 μl aliquots. To each aliquot CaM was added to a final concentration of 0, 10, 20, 100 or 200 nM. Reactions were incubated at 37
• C for 30 min, and 100 μl of ice-cold ethanol was added prior to centrifugation (11 000 g, 3 min, 4
• C). Supernatants were assayed for NO 2 − content using a Sievers 280A NO analyser, as described previously [6, 12, 13] .
Evaluation of NO synthesis in cells
HeLa cells cultured in 12-well plates were incubated in serumfree medium overnight. Cells were pre-incubated for 1 h at 37
• C in 0.5 ml/well KRH (Krebs Ringer Hepes) buffer [119 mM NaCl, 4.75 mM KCl, 1.2 mM MgSO 4 , 5 mM NaHCO 3 , 1.3 mM CaCl 2 , 20 mM Hepes/NaOH (pH 7.4.), 1.3 mM KH 2 PO 4 and 5 mM glucose]. The medium was removed and replaced with fresh KRH buffer (0.5 ml/well) in the presence of various concentrations of test substances. After incubation for various durations, aliquots of medium were removed and analysed using a Sievers 280A NO analyser, as described previously [6, 12, 13] . The appropriate control experiments were performed in the presence of the eNOS inhibitor L-NMMA (N G -monomethyl-L-arginine; 0.1 mM). Results are presented as L-NMMA-sensitive NO synthesis.
Statistics
Unless stated otherwise, results are expressed as the means + − S.E.M. Statistically significant differences were determined using a two-tailed Student's t test, with P < 0.05 deemed significant.
RESULTS
Insulin stimulated a significant increase in eNOS phosphorylation at Ser-1177 and Ser-615 in HAECs (approx. 1.7-fold), yet had no effect on eNOS phosphorylation at Ser-114, Thr-495 or Ser-633 (Figure 1 ). High (25 mM) culture glucose had no effect on basal or insulin-stimulated phosphorylation of eNOS at any site examined, with the exception of Ser-114, which demonstrated reduced phosphorylation (approx. 30 %) in the presence of insulin (Figure 1 ). Insulin-stimulated eNOS Ser-615 phosphorylation was inhibited by pre-incubation with wortmannin or infection of HAECs with Ad.PKB-DN (Figure 2) . Infection of HAECs with Ad.PKB-CA caused a significant increase in basal eNOS Ser-615 phosphorylation ( Figure 2 ). VEGF (vascular endothelial growth factor), which also stimulates PKB, stimulated eNOS Ser-615 phosphorylation, and insulin-stimulated Ser-615 phosphorylation was concomitant with Ser-1177 phosphorylation (results not shown).
AMPK (AMP-activated protein kinase) has also been demonstrated to phosphorylate and activate eNOS at Ser-1177 [12, 13, 15] . Incubation of HAECs with the AMPK activator phenformin stimulated phosphorylation of the AMPK substrate acetyl-CoA carboxylase and phosphorylation of eNOS at Ser-1177, without altering phosphorylation of eNOS at Ser-615 or PKB at Ser-473 (Figure 3 ). TNFα (tumour necrosis factor α) has been reported previously to inhibit insulin-stimulated NO synthesis and eNOS Ser-1179 (bovine equivalent to Ser-1177) phosphorylation in BAECs (bovine aortic endothelial cells) and reduce insulin receptor phosphorylation in HAECs [9, 16] . TNFα significantly attenuated insulin-stimulated eNOS Ser-615 phosphorylation and PKB Ser-473 phosphorylation in HAECs ( Figure 3 ).
As these findings indicate that insulin-stimulated phosphorylation of eNOS at both Ser-1177 and Ser-615 are mediated by PI3K/PKB, we reasoned that concurrent phosphorylation at both sites would influence eNOS activity. HeLa cells (with low endogenous expression of eNOS) were transfected with eNOS mutants in which Ser-615 and/or Ser-1177 had been mutated to alanine (phospho-null) or aspartic acid (phosphomimetic). Transfection efficiency was approximately equal in each case and mutation of Ser-615 had no effect on insulinstimulated Ser-1177 phosphorylation. Similarly, mutation of Ser-1177 had no effect on insulin-stimulated Ser-615 phosphorylation ( Figure 4A ). In unstimulated HeLa cells, Ser-615 and Ser-1177 phosphorylation was barely detectable (results not shown). ADP-Sepharose-purified extracts from untransfected HeLa cells exhibited low levels of NO synthesis that were not sensitive to CaM addition, whereas cells transfected with
Figure 2 Insulin-stimulated eNOS Ser-615 phosphorylation is PI3K/PKBdependent
Lysates were subjected to immunoblotting with the indicated antibodies after preparation from HAECs (A, B) incubated in the presence or absence of insulin (1 μM, 10 min) and wortmannin (100 nM, 45 min) or (C, D) infected with the indicated adenoviruses for 48 h, prior to incubation in the presence or absence of insulin (1 μM, 15 min). (A, C) Representative immunoblots are shown. (B, D) Quantification of immunoblots from three independent experiments. *P < 0.05 relative to vehicle; **P < 0.05 relative to the absence of wortmannin; ***P < 0.05 relative to the value in the presence of Ad.control.
wild-type human eNOS exhibited Ca
2+ -sensitive NO synthesis (Table 1) . Ca 2+ -sensitive NO synthesis was not significantly different in Ala-615 or Asp-615 mutants (Table 1) . In contrast, eNOS activity was significantly reduced at 200 nM CaM in the Ala-1177 mutant and significantly increased at 10-200 nM CaM in the Asp-1177 mutant ( Table 1) . Mutation of Ser-615 to alanine or aspartic acid had no significant effect on eNOS activity or Ca 2+ sensitivity in the Ala-1177 mutant, yet mutation of Ser-615 to alanine significantly reduced Asp-1177 mutant eNOS activity at 20-100 nM CaM and eNOS activity was significantly increased at 100-200 nM CaM in the double Asp-615/Asp-1177 mutant compared with the Asp-1177 single mutant (Table 1) .
Intact HeLa cells transfected with wild-type, Ala-615 or Asp-615 mutant eNOS exhibited insulin-stimulated NO synthesis, whereas NO synthesis was barely detectable in untransfected cells. Basal NO synthesis was significantly increased compared with wild-type in cells transfected with Asp-1177, Ala-615/ Asp-1177 and Asp-615/Asp-1177 mutant eNOS ( Figure 4B ). In addition, insulin-stimulated NO synthesis was significantly reduced in cells transfected with the Ala-615 mutant compared with wild-type ( Figure 4B ). 
DISCUSSION
The principal finding of the present study was that insulin rapidly stimulates phosphorylation of eNOS at Ser-615. Phosphorylation at Ser-615 was concomitant with insulinstimulated phosphorylation of eNOS at Ser-1177 and was attenuated by the PI3K inhibitor wortmannin or infection with adenoviruses expressing dominant-negative mutant PKB. Furthermore, down-regulation of Ser-615 phosphorylation attenuates insulin-stimulated NO synthesis.
Phosphorylation of eNOS at Ser-617 (bovine sequence) has been demonstrated previously in response to bradykinin, VEGF, ATP, endostatin and statins in BAECs [9] [10] [11] 17] . The present study represents the first evidence of Ser-615 phosphorylation in human endothelial cells and identifies insulin as a novel stimulus for Ser-615 phosphorylation. Inhibition of PI3K has been reported previously to attenuate bradykinin-and lovastatin-stimulated Ser-617 phosphorylation [10, 11] . Furthermore, the sequence surrounding Ser-615 forms a consensus PKB phosphorylation site, and recombinant PKB isolated from wortmannin-treated cells has a reduced capacity to phosphorylate eNOS Ser-617 in vitro [10] . In the present study, several lines of evidence support a role for PKB as the eNOS Ser-615 kinase: (i) infection with Ad.PKB-DN reduced insulin-stimulated Ser-615 phosphorylation; (ii) insulin-stimulated Ser-615 and Ser-1177 phosphorylation were concomitant and VEGF, which activates PKB in HAECs, stimulated Ser-615 phosphorylation [13] ; (iii) infection with Ad.PKB-CA stimulated eNOS Ser-615 phosphorylation; and (iv) insulin-stimulated phosphorylation of both eNOS at Ser-615 and PKB at Ser-473 is attenuated in HAECs pre-incubated with TNFα. Activation of AMPK with phenformin had no effect on Ser-615 phosphorylation, indicating that, unlike Ser-1177, Ser-615 is not a substrate for AMPK, yet we cannot rule out the possibility that a protein kinase downstream of PKB is responsible for insulinstimulated Ser-615 phosphorylation.
Insulin-stimulated Ser-1177 phosphorylation was unaffected by high glucose conditions, as described previously [6] . Furthermore, there was no significant change in either basal or insulinstimulated Ser-615 phosphorylation in response to high glucose, suggesting that Ser-615 phosphorylation is not impaired under high glucose culture conditions. Indeed, as PKB is likely to be responsible for both Ser-1177 and Ser-615 phosphorylation, it is expected that phosphorylation at both sites is unaffected.
NO synthesis by ADP-Sepharose-purified eNOS from unstimulated HeLa cell lysates was unaffected when eNOS was mutated to Ala-615 or Asp-615. However, in eNOS Asp-1177 mutants, the introduction of an additional Ala-615 mutation significantly reduced NO synthesis at 20-100 nM CaM, whereas the introduction of an additional Asp-615 mutation increased maximal NO synthesis. In previous studies, the Asp-617 mutation (bovine sequence) has been reported to increase the Ca 2+ -sensitivity of eNOS [10] or increase the V max of eNOS [9] in cellfree extracts. Very recently, it was reported that an Asp-617/Asp-1179-double mutant co-operatively increased Ca 2+ -sensitivity of eNOS compared with either mutation alone [18] , in agreement with the present study. In intact HeLa cells transfected with eNOS mutants, insulin-stimulated NO synthesis by the Ala-615 mutant was impaired compared with the wild-type enzyme, whereas the Asp-615 mutant alone had no significant effect on basal or insulin-stimulated NO synthesis. Previous studies have reported a reduction in eNOS V max (as assessed by citrulline production), yet modestly increased NO synthesis under ATPstimulated conditions in COS cells expressing an eNOS Ala-617 mutant [9] . Infection of BAECs with adenoviruses expressing Asp-617 mutant eNOS has been reported to significantly increase NO synthesis [19] . In addition, mutants in which Ser-617, Ser-635 and Ser-1177 were all mutated to alanine demonstrated reduced basal and ionomycin-stimulated NO synthesis when compared with wild-type enzyme [20] . In the present study, we have assayed eNOS-associated and cellular NO synthesis by a subtly different method. It is possible that the different assay methods, eNOS constructs used and stimuli may underlie the lack of effect of Asp-615 on the Ca 2+ -sensitivity or maximum rate of NO synthesis observed in the present study.
In agreement with our previous study, Thr-495 phosphorylation was unaffected by high glucose or insulin [6] . Similar studies in HUVECs (human umbilical vein endothelial cells) have demonstrated a rapid dephosphorylation of Thr-495 in response to insulin that was maximal within 2 min [21, 22] . The reasons for these conflicting results are uncertain, although the different vessels from which the cells were isolated or time course of insulin stimulation may underlie this. Phosphorylation at Ser-114 (bovine sequence Ser-116) has been demonstrated to be reduced in response to endostatin and VEGF in BAECs [17, 23] . Insulin stimulated a modest reduction in Ser-114 phosphorylation under high glucose conditions. Both dephosporylation [17, 23] and phosphorylation [24] of Ser-114 has been reported under conditions that activate eNOS, although infection with adenoviruses expressing Asp-116 mutant eNOS increased the association of eNOS with caveolin-1 and impaired NO synthesis in BAECs, and impaired relaxation in aortic rings from eNOSknockout mice, indicating that Ser-114 phosphorylation is inhibitory [19] .
In conclusion, we propose that upon insulin-mediated PKB stimulation, phosphorylation of both Ser-615 and Ser-1177 will increase NO synthesis when compared with agents that stimulate Ser-1177 alone, whereas phosphorylation of Ser-615 alone is not sufficient to stimulate eNOS activity. Further work is necessary to identify the insulin signalling mechanisms impaired by high glucose culture conditions. Such studies should include an analysis of the regulation of subcellular localization of eNOS and/or association of eNOS with caveolin-1 and/or Hsp90 (heatshock protein 90) [25, 26] .
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